Tatter, Stephen B.
Atrium Health Wake Forest Baptist · Wake Forest Baptist Comprehensive Cancer Center · Wake Forest University
3 papers on CoChatORCID 0000-0002-1063-0431
Most cited papers
- Verified
AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology
Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments
Cited by 681
- Verified
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease
Niethammer, M., Tang, C. C., LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Sarkar, A., et al. (2017) · JCI Insight
Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments
Cited by 124
- Verified
Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor
Renfrow, J. J., Soike, M. H., West, J. L., Ramkissoon, S. H., Metheny-Barlow, L., Mott, R. T., Kittel, C. A., D’Agostino, R. B., Tatter, S. B., Laxton, A. W., et al. (2020) · Scientific Reports
Cancer, Hypoxia, and MetabolismGlioma Diagnosis and Treatment
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free